US-EU Regulatory Cooperation: Lessons and Opportunities
by D. Pérez, S. Dudley, N. Eisner, R. Lutter, D. Zorn and N. Nord
Unnecessary regulatory differences between countries persist as lingering barriers to trade even as traditional barriers are declining.
The George Washington University Regulatory Studies Center prepared this report as part of a grant from the European Union to analyze opportunities to improve regulatory cooperation between the EU and U.S. The first chapter presents an overview of the research. The case studies in chapters three through five examine how regulatory cooperation has worked in practice between three U.S. regulatory agencies and their EU counterparts. The fifth chapter analyzes regulatory activity in the U.S. likely to have significant effects on international trade and investment. These analyses identify areas of opportunity that can help reduce incompatible approaches and unnecessary costs while indicating areas where regulatory divergences could persist due to jurisdictional judgements of national sovereignty and structural differences between countries.
Download the individual working papers:
Introduction: Experiences in International Regulatory Cooperation: Benefits, Limitations, and Best Practices, by Daniel R. Pérez & Susan E. Dudley
Improving Regulatory Cooperation Between the U.S. Food and Drug Administration and the EU, by Randall Lutter & David Zorn